Colorectal cancer
3D Printing Technology Enables Precise Fabrication of Delayed-Release Regorafenib Tablets
Researchers from the Tehran University of Medical Sciences have successfully developed a 3D printing technology to create once-daily, delayed-release regorafenib tablets for the treatment of colorectal cancer. The innovative approach uses a hydrogel containing 80 mg of the drug in a matrix of hyaluronic acid, carboxymethyl cellulose, Pluronic F127, and